PCN28 Relationship between Surrogate Endpoints and Overall Survival in Studies That Prohibited Crossover or Reported Balanced Post-Progression Treatments; Pooled Analysis in Advanced NSCLC Patients
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.165
https://www.valueinhealthjournal.com/article/S1098-3015(20)32421-9/fulltext
Title :
PCN28 Relationship between Surrogate Endpoints and Overall Survival in Studies That Prohibited Crossover or Reported Balanced Post-Progression Treatments; Pooled Analysis in Advanced NSCLC Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32421-9&doi=10.1016/j.jval.2020.08.165
First page :
Section Title :
Open access? :
No
Section Order :
10122